This interactive database, developed in collaboration with Henrik Zetterberg and colleagues, organizes the findings from cross-sectional studies investigating potential biomarkers in the CSF, plasma, and serum of Alzheimer's disease patients. It is a collection of curated measurements and related data from published studies as well as meta-analyses for select biomarkers. Coming in early 2015!
AlzGene is a collection of published Alzheimer's disease genetic association studies with random-effects meta-analyses for various polymorphisms.
AlzPedia serves as a quick reference guide that provides brief summaries of various genes and proteins implicated in the pathophysiology of Alzheimer’s disease and other neurodegenerative disorders.
AlzRisk is a collection of findings from published epidemiologic reports that evaluate environmental and other non-genetic risk factors for Alzheimer's disease. The database includes study summaries and meta-analyses, when applicable.
This database contains information about more than 30,000 antibodies related to the study of Alzheimer’s disease and other areas of neuroscience. Antibodies from both commercial and laboratory sources are included.
This database contains information about mutations in genes linked to autosomal-dominant Alzheimer’s disease as well as mutations in MAPT (tau). The goal is to provide a comprehensive list of rare variants in these genes, causative as well as benign, and to briefly describe the associated clinical and neuropathological features and reported functional effects.
This database contains information about over one hundered mouse models relevant to the study Alzheimer’s disease and related neurodegenerative diseases. This database is a work in progress and will be expanded over time.
This is a collection of detailed protocols, submitted from individual laboratories, which outline the reagents and experimental approaches used in different aspects of Alzheimer's disease research.
The Therapeutics Database provides information about drugs and other therapeutic approaches currently or previously tested in clinical trials for use in Alzheimer's disease and other neurodegenerative disorders.